Intuitive Surgical Inc (ISRG) operating KPIs
ISRGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 17/3023% above fair value
$432.01−16.75 (-3.73%)
Close on Oct 30, 2026Market cap $152.62BP/E 49.5Yield –
Intuitive Surgical ion Endoluminal Biopsy Procedures — Reported YoY Growth (%) (%)
Form 10-Q MD&A & Form 8-K Earnings Release
Latest, Q3 2026
31.0%
Period ended Sep 30, 2026
Change on a year earlier
-21.0 pts
52.0% in Q3 2025
History
10 quarters
Since Q1 2024
Sources
7
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Ion Endoluminal Biopsy Procedures — Reported YoY Growth (%) (%) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 31.0% | -21.0 pts | SEC Filing (0001035267-26-000067) ↗ |
| Q2 2026 | Jun 30, 2026 | 36.0% | -16.0 pts | SEC Filing (0001035267-26-000047) ↗ |
| Q1 2026 | Mar 31, 2026 | 39.0% | -19.0 pts | SEC Filing (0001035267-26-000029) ↗ |
| Q4 2025 | Dec 31, 2025 | 44.0% | – | SEC Filing (0001035267-26-000006) ↗ |
| Q3 2025 | Sep 30, 2025 | 52.0% | -21.0 pts | SEC Filing (0001035267-25-000209) ↗ |
| Q2 2025 | Jun 30, 2025 | 52.0% | -30.0 pts | SEC Filing (0001035267-25-000192) ↗ |
| Q1 2025 | Mar 31, 2025 | 58.0% | -32.0 pts | SEC Filing (0001035267-25-000109) ↗ |
| Q3 2024 | Sep 30, 2024 | 73.0% | – | SEC Filing (0001035267-25-000209) ↗ |
| Q2 2024 | Jun 30, 2024 | 82.0% | – | SEC Filing (0001035267-25-000192) ↗ |
| Q1 2024 | Mar 31, 2024 | 90.0% | – | SEC Filing (0001035267-25-000109) ↗ |
Cite this data
StockData. (2026). Intuitive Surgical Ion Endoluminal Biopsy Procedures — Reported YoY Growth (%) (%), quarterly Q1 2024–Q3 2026 [Data set]. Compiled from Intuitive Surgical SEC filings and investor materials. https://stockdatahq.com/stocks/isrg/kpis/ion-proc-yoy
See every metric in the Intuitive Surgical KPI table. Data updated Oct 28, 2026.